ストックスクリーナーアプリを入手
33.19
0.48%
-0.16
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Stockholders to Connect - Markets Insider
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Swiss National Bank - Defense World
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Harmony Biosciences appoints Adam Zaeske as Chief Commercial Officer - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference - Yahoo Finance
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Investors to Inquire about Securities Investigation - Markets Insider
Harmony Biosciences names new chief commercial officer By Investing.com - Investing.com Australia
Harmony Biosciences appoints Adam Zaeske as Chief Commercial Officer (HRMY:NASDAQ) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Reach Out - Markets Insider
Harmony Biosciences: A Compelling Risk-Reward Opportunity (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences names new chief commercial officer - Investing.com India
Harmony Biosciences Names Adam Zaeske As Chief Commercial Officer -March 24, 2025 at 08:25 am EDT - Marketscreener.com
Harmony Biosciences price target raised to $44 from $42 at Mizuho - MSN
Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands - Business Wire
HRMY Investors Have Opportunity to Join Harmony Biosciences Holdings, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Charles Schwab Investment Management Inc. Purchases 100,586 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
(HRMY) On The My Stocks Page - Stock Traders Daily
Amundi Acquires 13,041 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
HRMY Down 10.8% In Six Months: How Should You Play The Stock? - Barchart
HRMY Down 10.8% in Six Months: How Should You Play the Stock? - Nasdaq
Mizuho Issues Positive Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price - Defense World
HRMY Crosses Above Key Moving Average Level - Nasdaq
Expert Outlook: Harmony Biosciences Hldgs Through The Eyes Of 11 Analysts - Benzinga
Mizuho lifts Harmony Biosciences stock target to $44 - Investing.com India
Mizuho lifts Harmony Biosciences stock target to $44 By Investing.com - Investing.com South Africa
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc.HRMY - PR Newswire
Mizuho Adjusts PT on Harmony Biosciences Holdings to $44 From $42, Maintains Outperform Rating - Marketscreener.com
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $44 at Mizuho - StreetInsider.com
Victory Capital Management Inc. Has $5.05 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Bank of New York Mellon Corp - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Harmony Biosciences at Leerink Conference: Expanding Horizons in Rare Disorders - Investing.com UK
Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Repor - GuruFocus.com
Proficio Capital Partners LLC Buys New Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences to Present at Upcoming Global Healthcare Conferences - MSN
Harmony Biosciences Holdings, Inc. (HRMY): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - MSN
Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire
Amalgamated Bank Buys 2,074 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Principal Financial Group Inc. - Defense World
Equities Analysts Set Expectations for HRMY FY2025 Earnings - Defense World
Harmony Biosciences Reports Record 2024 Revenue, Targets Billion-Dollar Milestone in 2025 - MyChesCo
HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money - ACCESS Newswire
Harmony Biosciences Faces Regulatory Setback, Outlines Future Plans for Pitolisant - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Rhumbline Advisers Buys 16,537 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Denali Advisors LLC - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Releases Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
HC Wainwright Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $70.00 - MarketBeat
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):